Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Short term heart transplant outcomes with heart organ procurement services.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Resection of Intrapericardial Lymphangioma Invasive to Ventricular Apex via Left Anterolateral Thoracotomy.

Annals of thoracic surgery short reports·2026
Same author

A retrospective pilot crossover study of protocolized transition from inhaled nitric oxide to inhaled epoprostenol in adult cardiothoracic surgery.

JHLT open·2026
Same author

Acute HeartMate3 Malfunction Requiring Exchange Due to Intrapump Obstruction: Inflow Cannula Obstruction Can Cause HM3 Failure.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same author

Impact of Impella Support as a Bridge to Durable Left Ventricular Assist Device on Aortic Regurgitation Progression and Long-Term Survival.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same author

Listing patterns at the highest volume heart transplant centers: Multiple roads to transplant.

JHLT open·2026

Related Experiment Video

Updated: May 29, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Clinical trials in mechanical circulatory support.

Gregory Egnaczyk1, Carmelo A Milano, Joseph G Rogers

  • 1Division of Cardiology, Duke University Medical Center, Durham, NC 27710, USA.

Heart Failure Clinics
|September 20, 2011
PubMed
Summary

Mechanically assisted circulation using ventricular assist devices (VADs) improves survival and quality of life for advanced heart failure patients. Further benefits are expected when VADs are used in less critical patient groups.

More Related Videos

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Related Experiment Videos

Last Updated: May 29, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Area of Science:

  • Cardiovascular Medicine
  • Biomedical Engineering

Background:

  • Advanced heart failure presents significant challenges in patient management.
  • Mechanically assisted circulation offers a therapeutic option for end-stage heart disease.

Purpose of the Study:

  • To evaluate the impact of recent advancements in ventricular assist devices (VADs) on patient outcomes.
  • To assess the role of innovative trial designs in supporting VAD technology.

Main Methods:

  • Review of cumulative data from trials employing novel designs and endpoints.
  • Analysis of patient selection criteria and device enhancements.

Main Results:

  • Improvements in survival, functionality, and quality of life observed.
  • Reductions in adverse events associated with VADs.
  • Significant patient-centric outcome improvements documented.

Conclusions:

  • Current VAD technology demonstrates robust benefits for advanced heart failure.
  • Expansion of VADs to less critical populations may yield even greater advantages.
  • Continued innovation in VADs and trial methodologies is crucial.